Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Department of Pharmacy, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou 450000, China.
Acta Pharmacol Sin. 2022 Mar;43(3):703-711. doi: 10.1038/s41401-021-00673-w. Epub 2021 May 20.
Targeting autophagy might be a promising anticancer strategy; however, the dual roles of autophagy in cancer development and malignancy remain unclear. NSCLC (non-small cell lung cancer) cells harbour high levels of SQSTM1 (sequestosome 1), the autophagy receptor that is critical for the dual roles of autophagy. Therefore, mechanistic insights into SQSTM1 modulation may point towards better approaches to treat NSCLC. Herein, we used multiple autophagy flux models and autophagy readouts to show that aldo-keto reductase family 1 member C1 (AKR1C1), which is highly expressed in NSCLC, promotes autophagy by directly binding to SQSTM1 in a catalytic-independent manner. This interaction may be strengthened by reactive oxygen species (ROS), important autophagy inducers. Further mechanistic research demonstrated that AKR1C1 interacts with SQSTM1 to augment SQSTM1 oligomerization, contributing to the SQSTM1 affinity for binding cargo. Collectively, our data reveal a catalytic-independent role of AKR1C1 for interacting with SQSTM1 and promoting autophagy. All these findings not only reveal a novel functional role of AKR1C1 in the autophagy process but also indicate that modulation of the AKR1C1-SQSTM1 interaction may be a new strategy for targeting autophagy.
靶向自噬可能是一种有前途的抗癌策略;然而,自噬在癌症发展和恶性肿瘤中的双重作用仍不清楚。非小细胞肺癌 (NSCLC) 细胞中含有高水平的 SQSTM1(自噬受体),自噬受体对自噬的双重作用至关重要。因此,对 SQSTM1 调节的机制研究可能为治疗 NSCLC 提供更好的方法。在此,我们使用多种自噬通量模型和自噬读数来表明,在 NSCLC 中高度表达的醛酮还原酶家族 1 成员 C1 (AKR1C1) 通过直接与 SQSTM1 结合以催化非依赖性方式促进自噬。这种相互作用可能会被重要的自噬诱导剂活性氧 (ROS) 增强。进一步的机制研究表明,AKR1C1 与 SQSTM1 相互作用以增强 SQSTM1 寡聚化,从而增强 SQSTM1 与货物结合的亲和力。总的来说,我们的数据揭示了 AKR1C1 在与 SQSTM1 相互作用和促进自噬中具有催化非依赖性的作用。所有这些发现不仅揭示了 AKR1C1 在自噬过程中的新功能作用,还表明 AKR1C1-SQSTM1 相互作用的调节可能是靶向自噬的一种新策略。